Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Traunecker

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Annales D'Immunologie|January 1, 1977
[In vitro differentiation of B lymphocytes]L Lafleur, A Traunecker
European Journal of Immunology|July 1, 1986
A novel approach for preparing anti-T cell receptor constant region antibodiesA Traunecker, B Dolder, K Karjalainen
Trends in Biotechnology|April 1, 1991
Myeloma based expression system for production of large mammalian proteinsA Traunecker, F Oliveri, K Karjalainen
The EMBO Journal|December 1, 1991
Bispecific single chain molecules (Janusins) target cytotoxic lymphocytes on HIV infected cellsA Traunecker, A Lanzavecchia, K Karjalainen
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1992
Janusin: new molecular design for bispecific reagentsA Traunecker, A Lanzavecchia, K Karjalainen
European Journal of Immunology|February 1, 1993
Constitutive expression of high levels of soluble mouse CD4 in transgenic mice does not interfere with their immune functionS Weber, A Traunecker, K Karjalainen
The Journal of Experimental Medicine|February 1, 1984
Somatic mutation creates diversity in the major group of mouse immunoglobulin kappa light chainsG Heinrich, A Traunecker, S Tonegawa
European Journal of Immunology|February 1, 1993
The T cell receptor alpha beta V-J shuffling shows lack of autonomy between the combining site and the constant domain of the receptor chainsG Casorati, A Traunecker, K Karjalainen
The EMBO Journal|July 1, 1987
A new mouse TCR V gamma gene that shows remarkable evolutionary conservationJ Pelkonen, A Traunecker, K Karjalainen
Nature|January 7, 1988
Soluble CD4 molecules neutralize human immunodeficiency virus type 1A Traunecker, W Lüke, K Karjalainen
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Annales D'Immunologie|January 1, 1977
[In vitro differentiation of B lymphocytes]L Lafleur, A Traunecker
European Journal of Immunology|July 1, 1986
A novel approach for preparing anti-T cell receptor constant region antibodiesA Traunecker, B Dolder, K Karjalainen
Trends in Biotechnology|April 1, 1991
Myeloma based expression system for production of large mammalian proteinsA Traunecker, F Oliveri, K Karjalainen
The EMBO Journal|December 1, 1991
Bispecific single chain molecules (Janusins) target cytotoxic lymphocytes on HIV infected cellsA Traunecker, A Lanzavecchia, K Karjalainen
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1992
Janusin: new molecular design for bispecific reagentsA Traunecker, A Lanzavecchia, K Karjalainen
European Journal of Immunology|February 1, 1993
Constitutive expression of high levels of soluble mouse CD4 in transgenic mice does not interfere with their immune functionS Weber, A Traunecker, K Karjalainen
The Journal of Experimental Medicine|February 1, 1984
Somatic mutation creates diversity in the major group of mouse immunoglobulin kappa light chainsG Heinrich, A Traunecker, S Tonegawa
European Journal of Immunology|February 1, 1993
The T cell receptor alpha beta V-J shuffling shows lack of autonomy between the combining site and the constant domain of the receptor chainsG Casorati, A Traunecker, K Karjalainen
The EMBO Journal|July 1, 1987
A new mouse TCR V gamma gene that shows remarkable evolutionary conservationJ Pelkonen, A Traunecker, K Karjalainen
Nature|January 7, 1988
Soluble CD4 molecules neutralize human immunodeficiency virus type 1A Traunecker, W Lüke, K Karjalainen
Pageof 3